MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- CorVita Science Foundation
- Study ID
- NCT05978466
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.
Key Dates
- Start date
- Dec 22, 2017
- Status verified
- Jan 2024
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Recurrence of Atrial fibrillation [ Time Frame: From enrollment to 10- year study completion ]
Central Contacts
- Edward M Burke773-432-4888
- Martin C Burke, DO773-432-4888
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CorVita Science Foundation (NFP) | Chicago | Illinois | 60605 | Martin C Burke, DO (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
Related Studies
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- CardioFocus HeartLight Post-Approval StudyRecruiting · CardioFocus · Tucson, Arizona
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama